These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Glucagon use by U.S. adults with type 1 and type 2 diabetes. Kahn PA, Liu S, McCoy R, Gabbay RA, Lipska K. J Diabetes Complications; 2021 May; 35(5):107882. PubMed ID: 33593689 [Abstract] [Full Text] [Related]
9. Clinical evaluation of biosynthetic glucagon treatment for recovery from hypoglycemia developed in diabetic patients. The GL-G Hypoglycemia Study Group. Namba M, Hanafusa T, Kono N, Tarui S. Diabetes Res Clin Pract; 1993 Feb; 19(2):133-8. PubMed ID: 8472628 [Abstract] [Full Text] [Related]
10. HYPOGLYCEMIA IN THE ELDERLY WITH DIABETES: A GROWING PROBLEM WITH EMERGING SOLUTIONS. Grajower MM. Endocr Pract; 2018 Mar; 24(3):312-314. PubMed ID: 29547043 [Abstract] [Full Text] [Related]
11. Glucagon prescribing and prevention of hospitalization for hypoglycemia in a large health system. Herges JR, Haag JD, Kosloski Tarpenning KA, Mara KC, McCoy RG. Diabetes Res Clin Pract; 2023 Aug; 202():110832. PubMed ID: 37453512 [Abstract] [Full Text] [Related]
12. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Leese GP, Wang J, Broomhall J, Kelly P, Marsden A, Morrison W, Frier BM, Morris AD, DARTS/MEMO Collaboration. Diabetes Care; 2003 Apr; 26(4):1176-80. PubMed ID: 12663593 [Abstract] [Full Text] [Related]
13. Hypoglycemia-related emergency department visits and hypoglycemia-related hospitalizations among new users of antidiabetes treatments. Moisan J, Breton MC, Villeneuve J, Grégoire JP. Can J Diabetes; 2013 Jun; 37(3):143-9. PubMed ID: 24070836 [Abstract] [Full Text] [Related]
14. The burden of severe hypoglycemia in type 1 diabetes. Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J. Curr Med Res Opin; 2018 Jan; 34(1):171-177. PubMed ID: 29019269 [Abstract] [Full Text] [Related]
15. National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations. Geller AI, Shehab N, Lovegrove MC, Kegler SR, Weidenbach KN, Ryan GJ, Budnitz DS. JAMA Intern Med; 2014 May; 174(5):678-86. PubMed ID: 24615164 [Abstract] [Full Text] [Related]
16. New Fast Acting Glucagon for Recovery from Hypoglycemia, a Life-Threatening Situation: Nasal Powder and Injected Stable Solutions. La Sala L, Pontiroli AE. Int J Mol Sci; 2021 Sep 30; 22(19):. PubMed ID: 34638984 [Abstract] [Full Text] [Related]
17. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality? Pontiroli AE, Ceriani V. Diabetes Obes Metab; 2018 Aug 30; 20(8):1812-1816. PubMed ID: 29652110 [Abstract] [Full Text] [Related]
19. Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in Taiwan. Chen YJ, Yang CC, Huang LC, Chen L, Hwu CM. Prim Care Diabetes; 2015 Dec 30; 9(6):490-6. PubMed ID: 25937182 [Abstract] [Full Text] [Related]